IMDX
Insight Molecular Diagnostics Inc.
NASDAQHealthcareMedical - Diagnostics & ResearchUS
Rating:C
Company Profile
CEO
Joshua Riggs
IPO Date
2015-12-30
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Insight Molecular Diagnostics Inc.
CEO
Joshua Riggs
IPO Date
2015-12-30
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
| $5.69 |
| 6 Jul 2026 | Arno Andrew | director | F-InKind | Disposed | 12,100 | $5.69 |
| 15 Jun 2026 | SILVERMAN LOU | director | A-Award | Acquired | 26,943 | $0.00 |
| 15 Jun 2026 | Last Andrew J. | director | A-Award | Acquired | 26,943 | $0.00 |
| 15 Jun 2026 | Arno Andrew | director | A-Award | Acquired | 32,331 | $0.00 |
| 27 Apr 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | P-Purchase | Acquired | 280,381 | $3.50 |
| 27 Apr 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | P-Purchase | Acquired | 0 | $0.00 |
| 27 Apr 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | P-Purchase | Acquired | 38,880 | $3.53 |
| 27 Apr 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | P-Purchase | Acquired | 0 | $0.00 |